查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
數位定量吸入器的全球市場:產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)
市場調查報告書
商品編碼
1121670

數位定量吸入器的全球市場:產業分析，規模，佔有率，成長，趨勢，預測(2022年～2031年)

Digital Dose Inhalers Market (Product: Metered Dose Inhalers and Dry Powder Inhalers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日期: | 出版商: Transparency Market Research | 英文 163 Pages | 商品交期: 2-10個工作天內

價格

本報告提供全球數位定量吸入器的市場調查分析，市場概要，對市場成長的各種影響因素，各市場區隔、各地區的分析與預測，競爭情形，主要企業簡介等彙整資訊。

目錄

第1章 序文

第2章 前提與調查手法

第3章 摘要整理:全球數位定量吸入器市場

第4章 市場概要

  • 簡介
    • 產品定義
    • 產業的演進/發展
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球數位定量吸入器市場分析與預測(2017年～2031年)
    • 市場收益預測

第5章 市場預測

  • 技術的進步
  • 主要的產業活動(合併，收購，產品發表等)
  • 氣喘，COPD(慢性阻塞性肺病)等的呼吸疾病流行病學

第6章 全球數位定量吸入器市場分析與預測:各產品

  • 簡介和定義
  • 主要調查結果/開發
  • 市場價值預測:各產品(2017年～2031年)
    • 定量吸入器
    • 乾粉吸入劑
  • 市場魅力分析:各產品

第7章 全球數位定量吸入器市場分析與預測:各用途

  • 簡介和定義
  • 主要調查結果/開發
  • 市場價值預測:各用途(2017年～2031年)
    • 氣喘
    • COPD(慢性阻塞性肺病)
    • 其他
  • 市場魅力分析:各用途

第8章 全球數位定量吸入器市場分析與預測:各地區

  • 主要調查結果
  • 市場價值預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場魅力分析:各地區

第9章 北美的數位定量吸入器市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各產品(2017年～2031年)
    • 定量吸入器
    • 乾粉吸入劑
  • 市場價值預測:各用途(2017年～2031年)
    • 氣喘
    • COPD(慢性阻塞性肺病)
    • 其他
  • 市場價值預測:各國(2017年～2031年)
    • 美國
    • 加拿大
  • 市場魅力分析
    • 各產品
    • 各用途
    • 各國

第10章 歐洲的數位定量吸入器市場分析與預測

第11章 亞太地區的數位定量吸入器市場分析與預測

第12章 南美的數位定量吸入器市場分析與預測

第13章 中東、非洲的數位定量吸入器市場分析與預測

第14章 競爭情形

  • 市場企業 - 競爭矩陣
  • 市場佔有率/地位分析:各企業(2021年)
  • 企業簡介
    • Novartis AG
    • AstraZeneca
    • Glenmark
    • GlaxoSmithKline plc
    • Teva Pharmaceutical Industries Ltd.
    • 3M
    • Sensirion AG Switzerland
    • AptarGroup, Inc.
    • Cipla, Inc.
    • H&T Presspart Manufacturing Ltd.
Product Code: TMRGL18881

The report provides revenue of the global digital dose inhalers market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global digital dose inhalers market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the digital dose inhalers market.

The report delves into the competitive landscape of the global digital dose inhalers market. Key players operating in the global digital dose inhalers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global digital dose inhalers market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Digital Dose Inhalers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Digital Dose Inhalers Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

  • 5.1. Technological Advancements
  • 5.2. Key Industry Events (Mergers, Acquisitions, Product Launch , etc.)
  • 5.3. Epidemiology of Respiratory Diseases, such as Asthma, COPD (Chronic Obstructive Pulmonary Disease),etc.

6. Global Digital Dose Inhalers Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Metered Dose Inhalers
    • 6.3.2. Dry Powder Inhalers
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Digital Dose Inhalers Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Asthma
    • 7.3.2. COPD (chronic obstructive pulmonary disease)
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Digital Dose Inhalers Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Digital Dose Inhalers Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Product, 2017-2031
    • 9.2.1. Metered Dose Inhalers
    • 9.2.2. Dry Powder Inhalers
  • 9.3. Market Value Forecast, by Application, 2017-2031
    • 9.3.1. Asthma
    • 9.3.2. COPD (chronic obstructive pulmonary disease)
    • 9.3.3. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By Application
    • 9.5.3. By Country

10. Europe Digital Dose Inhalers Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Metered Dose Inhalers
    • 10.2.2. Dry Powder Inhalers
  • 10.3. Market Value Forecast, by Application, 2017-2031
    • 10.3.1. Asthma
    • 10.3.2. COPD (chronic obstructive pulmonary disease)
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Spain
    • 10.4.5. Italy
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By Application
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Digital Dose Inhalers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Metered Dose Inhalers
    • 11.2.2. Dry Powder Inhalers
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Asthma
    • 11.3.2. COPD (chronic obstructive pulmonary disease)
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Application
    • 11.5.3. By Country/Sub-region

12. Latin America Digital Dose Inhalers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Metered Dose Inhalers
    • 12.2.2. Dry Powder Inhalers
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Asthma
    • 12.3.2. COPD (chronic obstructive pulmonary disease)
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Application
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Digital Dose Inhalers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Metered Dose Inhalers
    • 13.2.2. Dry Powder Inhalers
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Asthma
    • 13.3.2. COPD (chronic obstructive pulmonary disease)
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Israel
    • 13.4.4. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By Application
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share/Position Analysis, by Company, 2021
  • 14.3. Company Profiles
    • 14.3.1. Novartis AG
      • 14.3.1.1. Company Overview
      • 14.3.1.2. Company Financials
      • 14.3.1.3. Growth Strategies
      • 14.3.1.4. SWOT Analysis
    • 14.3.2. AstraZeneca
      • 14.3.2.1. Company Overview
      • 14.3.2.2. Company Financials
      • 14.3.2.3. Growth Strategies
      • 14.3.2.4. SWOT Analysis
    • 14.3.3. Glenmark
      • 14.3.3.1. Company Overview
      • 14.3.3.2. Company Financials
      • 14.3.3.3. Growth Strategies
      • 14.3.3.4. SWOT Analysis
    • 14.3.4. GlaxoSmithKline plc
      • 14.3.4.1. Company Overview
      • 14.3.4.2. Company Financials
      • 14.3.4.3. Growth Strategies
      • 14.3.4.4. SWOT Analysis
    • 14.3.5. Teva Pharmaceutical Industries Ltd.
      • 14.3.5.1. Company Overview
      • 14.3.5.2. Company Financials
      • 14.3.5.3. Growth Strategies
      • 14.3.5.4. SWOT Analysis
    • 14.3.6. 3M
      • 14.3.6.1. Company Overview
      • 14.3.6.2. Company Financials
      • 14.3.6.3. Growth Strategies
      • 14.3.6.4. SWOT Analysis
    • 14.3.7. Sensirion AG Switzerland
      • 14.3.7.1. Company Overview
      • 14.3.7.2. Company Financials
      • 14.3.7.3. Growth Strategies
      • 14.3.7.4. SWOT Analysis
    • 14.3.8. AptarGroup, Inc.
      • 14.3.8.1. Company Overview
      • 14.3.8.2. Company Financials
      • 14.3.8.3. Growth Strategies
      • 14.3.8.4. SWOT Analysis
    • 14.3.9. Cipla, Inc.
      • 14.3.9.1. Company Overview
      • 14.3.9.2. Company Financials
      • 14.3.9.3. Growth Strategies
      • 14.3.9.4. SWOT Analysis
    • 14.3.10. H&T Presspart Manufacturing Ltd.
      • 14.3.10.1. Company Overview
      • 14.3.10.2. Company Financials
      • 14.3.10.3. Growth Strategies
      • 14.3.10.4. SWOT Analysis

Note: Financial details for companies that do not report this information in public domain might not be captured

List of Tables

  • Table 01: Epidemiology of Respiratory Diseases, such as Asthma, COPD (Chronic Obstructive Pulmonary Disease), etc.
  • Table 02: Epidemiology of Respiratory Diseases, such as Asthma, COPD (Chronic Obstructive Pulmonary Disease), etc.
  • Table 03: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 04: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 05: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 08: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 11: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 14: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 17: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 18: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 19: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Product, 2017-2031
  • Table 20: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031

List of Figures

  • Figure 01: Global Digital Dose Inhalers Market Size (US$ Mn) and Distribution, by Region, 2021 and 2031
  • Figure 02: Global Digital Dose Inhalers Market Revenue (US$ Mn), by Product, 2021
  • Figure 03: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 04: Global Digital Dose Inhalers Market Value Share (%), by Product, 2021 and 2031
  • Figure 05: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Metered Dose Inhalers, 2017-2031
  • Figure 06: Global Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Dry Powder Inhalers, 2017-2031
  • Figure 07: Global Digital Dose Inhalers Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 08: Global Digital Dose Inhalers Market Value Share, by Application, 2021 and 2031
  • Figure 09: Global Digital Dose Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 10: Global Digital Dose Inhalers Market Value (US$ Mn) and Y-o-Y Growth, by Asthma, 2017-2031
  • Figure 11: Global Digital Dose Inhalers Market Value (US$ Mn) and Y-o-Y Growth, by COPD (chronic obstructive pulmonary disease), 2017-2031
  • Figure 12: Global Digital Dose Inhalers Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2017-2031
  • Figure 13: Global Digital Dose Inhalers Market Value Share, by Region, 2021 and 2031
  • Figure 14: Global Digital Dose Inhalers Market Attractiveness Analysis, by Region, 2017-2031
  • Figure 15: North America Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 16: North America Digital Dose Inhalers Market Value Share (%), by Country, 2021 and 2031
  • Figure 17: North America Digital Dose Inhalers Market Attractiveness Analysis, by Country, 2017-2031
  • Figure 18: North America Digital Dose Inhalers Market Value Share, by Product, 2021 and 2031
  • Figure 19: North America Digital Dose Inhalers Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 20: North America Digital Dose Inhalers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 21: North America Digital Dose Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 22: Europe Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 23: Europe Digital Dose Inhalers Market Value Share (%), by Country / Sub-region, 2021 and 2031
  • Figure 24: Europe Digital Dose Inhalers Market Attractiveness Analysis, by Country / Sub-region, 2017-2031
  • Figure 25: Europe Digital Dose Inhalers Market Value Share, by Product, 2021 and 2031
  • Figure 26: Europe Digital Dose Inhalers Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 27: Europe Digital Dose Inhalers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 28: Europe Digital Dose Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 29: Asia Pacific Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 30: Asia Pacific Digital Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 31: Asia Pacific Digital Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 32: Asia Pacific Digital Dose Inhalers Market Value Share, by Product, 2021 and 2031
  • Figure 33: Asia Pacific Digital Dose Inhalers Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 34: Asia Pacific Digital Dose Inhalers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 35: Asia Pacific Digital Dose Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 36: Latin America Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 37: Latin America Digital Dose Inhalers Market Value Share (%), by Country / Sub-region, 2021 and 2031
  • Figure 38: Latin America Digital Dose Inhalers Market Attractiveness Analysis, by Country / Sub-region, 2017-2031
  • Figure 39: Latin America Digital Dose Inhalers Market Value Share, by Product, 2021 and 2031
  • Figure 40: Latin America Digital Dose Inhalers Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 41: Latin America Digital Dose Inhalers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 42: Latin America Digital Dose Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 43: Middle East & Africa Digital Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 44: Middle East & Africa Digital Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 45: Middle East & Africa Digital Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 46: Middle East & Africa Digital Dose Inhalers Market Value Share, by Product, 2021 and 2031
  • Figure 47: Middle East & Africa Digital Dose Inhalers Market Attractiveness Analysis, by Product, 2017-2031
  • Figure 48: Middle East & Africa Digital Dose Inhalers Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 49: Middle East & Africa Digital Dose Inhalers Market Attractiveness, by Application, 2017-2031
  • Figure 50: Novartis AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2021
  • Figure 51: Novartis AG R&D Intensity and Sales & Marketing Intensity - Company Level, 2017-2021
  • Figure 52: Novartis AG Breakdown of Net Sales (%), by Region, 2021
  • Figure 53: Novartis AG Breakdown of Net Sales (%), by Business Segment, 2021
  • Figure 54: AstraZeneca Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2021
  • Figure 55: AstraZeneca R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2021
  • Figure 56: AstraZeneca Breakdown of Net Sales (%), by Region, 2021
  • Figure 57: AstraZeneca Respiratory Segment Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2021
  • Figure 58: Glenmark (US$ Mn) Revenue, 2017-2021
  • Figure 59: Distribution of Glenmark Revenue (%), by Region, 2021
  • Figure 60: GlaxoSmithKline plc. Revenue (US$ Mn), 2017-2021
  • Figure 61: GlaxoSmithKline plc. R&D Expenses (US$ Mn), 2017-2021
  • Figure 62: GlaxoSmithKline plc. Breakdown of Net Sales (%), by Region, 2021
  • Figure 63: GlaxoSmithKline plc. Breakdown of Net Sales (%), by Business Segment, 2021
  • Figure 64: Teva Pharmaceutical Industries Ltd Revenue (US$ Mn) and Y-o-Y Growth (%), 2016-2021
  • Figure 65: Teva Pharmaceutical Industries Ltd R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016-2021
  • Figure 66: Teva Pharmaceutical Industries Ltd Breakdown of Net Sales (%), by Region, 2021
  • Figure 67: 3M , Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2021
  • Figure 68: 3M , R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2016-2021
  • Figure 69: 3M, Breakdown of Net Sales (%), by Region, 2021
  • Figure 70: 3M Breakdown of Net Sales (%), by Business Segment, 2021
  • Figure 71: Sensirion AG Switzerland, Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2021
  • Figure 72: Sensirion AG Switzerland, R&D Expenses (US$ Mn), 2017-2021
  • Figure 73: Sensirion AG Switzerland, Breakdown of Net Sales (%), by Region, 2021
  • Figure 74: Sensirion AG Switzerland, Breakdown of Net Sales (%), by Business Segment, 2021
  • Figure 75: AptarGroup, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2016-2021
  • Figure 76: AptarGroup, Inc., R&D Expenses (US$ Mn), 2016-2021
  • Figure 77: AptarGroup, Inc., Breakdown of Net Sales (%), by Region, 2021
  • Figure 78: AptarGroup, Inc., Breakdown of Net Sales (US$ Mn), by Business Segment, 2021
  • Figure 79: Cipla Inc., Revenue (US$ Mn), 2017-2021
  • Figure 80: Cipla Inc., Breakdown of Net Sales (%), by Region, 2021
  • Figure 81: Cipla Inc., Breakdown of Net Sales (%), by Business Segment, 2021